Back to trial details

Intake questionnaire

OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition

Applying to University of Pennsylvania · Philadelphia, Pennsylvania

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Malignant Pleural Mesothelioma?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Philadelphia for study visits?